Artisan Partners Limited Partnership Sarepta Therapeutics, Inc. Transaction History

Artisan Partners Limited Partnership

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	SELL	$102.5 - $123.59 $109,060 - $131,499	-1,064 Reduced 0.24%	439,807 $53.3 Million
Q2 2023 Aug 10, 2023	BUY	$106.4 - $157.19 $287,812 - $425,198	2,705 Added 0.62%	440,871 $50.5 Million
Q1 2023 May 11, 2023	BUY	$117.53 - $155.99 $51.5 Million - $68.3 Million	438,166 New	438,166 $60.4 Million
Q1 2021 May 11, 2021	SELL	$72.25 - $168.95 $38.4 Million - $89.7 Million	-531,012 Closed	0 $0
Q4 2020 Feb 10, 2021	SELL	$125.56 - $178.74 $2.77 Million - $3.95 Million	-22,097 Reduced 4.0%	531,012 $90.5 Million
Q3 2020 Nov 12, 2020	BUY	$127.12 - $172.34 $807,466 - $1.09 Million	6,352 Added 1.16%	553,109 $77.7 Million
Q2 2020 Aug 12, 2020	BUY	$93.0 - $171.7 $4 Million - $7.39 Million	43,026 Added 8.54%	546,757 $87.7 Million
Q1 2020 May 12, 2020	SELL	$82.38 - $131.64 $1.33 Million - $2.13 Million	-16,164 Reduced 3.11%	503,731 $49.3 Million
Q4 2019 Feb 12, 2020	SELL	$76.53 - $135.58 $9.24 Million - $16.4 Million	-120,744 Reduced 18.85%	519,895 $67.1 Million
Q3 2019 Nov 12, 2019	BUY	$72.81 - $156.91 $46.6 Million - $101 Million	640,639 New	640,639 $48.3 Million

529

84.2M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Artisan Partners Limited Partnership, based on Form 13F filings with the SEC.

Stay updated on Artisan Partners Limited Partnership with notifications on news.